ExodusPoint Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,501
Closed -$705K 1932
2025
Q3
$705K Buy
+5,501
New +$671K 0.01% 1078
2024
Q3
Sell
-120,170
Closed -$12.8M 1971
2024
Q2
$12.8M Buy
+120,170
New +$12.1M 0.14% 211
2023
Q3
Sell
-73,754
Closed -$7.44M 2016
2023
Q2
$7.44M Sell
73,754
-96,940
-57% -$9.7M 0.09% 317
2023
Q1
$15.7M Buy
+170,694
New +$14.9M 0.18% 168
2022
Q4
Sell
-108,751
Closed -$8.27M 1978
2022
Q3
$8.27M Buy
108,751
+102,783
+1,722% +$8.52M 0.12% 258
2022
Q2
$504K Buy
+5,968
New +$524K 0.01% 1344
2022
Q1
Sell
-6,880
Closed -$602K 2542
2021
Q4
$602K Buy
+6,880
New +$571K 0.01% 1305
2020
Q4
Sell
-16,297
Closed -$1.42M 2270
2020
Q3
$1.42M Buy
+16,297
New +$1.41M 0.04% 529
2020
Q2
Sell
-2,546
Closed -$210K 1949
2020
Q1
$210K Sell
2,546
-13,951
-85% -$1.24M 0.02% 771
2019
Q4
$1.56M Buy
16,497
+6,794
+70% +$610K 0.04% 407
2019
Q3
$843K Buy
+9,703
New +$871K 0.03% 442
2019
Q1
Sell
-3,156
Closed -$243K 737
2018
Q4
$243K Buy
+3,156
New +$246K 0.02% 230

Other funds holding NVS